NCT04156191 - Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema | Biotech Hunter

Enrollment

101

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

May 2, 2023

Study Completion Date

May 2, 2023

Conditions

Atopic Dermatitis (Eczema)

Interventions

DRUG

ARQ-151 cream 0.15%

ARQ-151 cream 0.15% applied to atopic dermatitis lesions once a day for 28 days

DRUG

ARQ-151 cream 0.05%

ARQ-151 cream 0.05% applied to atopic dermatitis lesions once a day for 28 days

Trial Locations (10)

Arcutis Clinical Site 01, Mt. Pleasant

Arcutis Clinical Site 05, Hialeah

Arcutis Clinical Site 13, Miami

Arcutis Clinical Site 02, Coral Gables

Arcutis Clinical Site 07, Birmingham

Arcutis Clinical Site 06, San Antonio

Arcutis Clinical Site 03, Orem

Arcutis Clinical Site 10, West Jordan

Arcutis Clinical Site 11, Rancho Santa Margarita

Arcutis Clinical Site 12, Spokane